Veracyte Inc Investor Call on ASCO Findings Transcript
Good day, and thank you for standing by. Welcome to the Veracyte investor call on ASCO findings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker. Kelly Gura, Director of Investor Relations. Please go ahead, ma'am.
Good morning, and thank you for joining us today to discuss key findings from the 2026 ASCO annual meeting. Before we begin, please note that we will make forward-looking statements, including statements regarding our product, clinical evidence, commercialization plans, reimbursement, market opportunities, and expected timing.
These statements are subject to risks and uncertainties that could cause actual results to differ materially. Please refer to Veracyte's SEC filings, including its most recent Forms 10-K and 10-Q, for a discussion of these risks. Veracyte undertakes no obligation to update forward-looking statements except as required. We will refer to the slides
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
